RNF43 and cancer: We next investigated whether truncated RNF43 interferes with the β‐catenin destruction complex, which provides a central point for Wnt pathway regulation and is commonly targeted by inactivating mutations in cancer (Polakis, 2012; Zhan et al, 2017).